Your search for

146 results were returned

  1. Twobirds news
    24 May 2019
    Bird & Bird advises FUJIFILM on the 100% acquisition of medwork
    www.twobirds.com/en/news/press-releases/2019/germany/bird-and-bird-advises-fujifilm-on-the-100-acquisition-of-medwork

    International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy

  2. Twobirds news
    05 April 2019
    Bird & Bird advises Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in Vakzine Projekt Management GmbH
    www.twobirds.com/en/news/press-releases/2019/germany/bird-and-bird-advises-serum-institute-of-india-pvt-ltd-on-the

    International law firm Bird & Bird advises Indian vaccine manufacturer Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in German project management service provider Vakzine Projekt Management ...

  3. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  4. Legal news
    19 October 2018
    Brexit: Life Sciences implications
    www.twobirds.com/en/news/articles/2016/uk/brexit-life-sciences-implications

    The UK’s Article 50 notice expiry has been extended by agreement from the original deadline of 29 March 2019 to 31 October 2019. The possibility of a no-deal Brexit at the end of October still remains.